Literature DB >> 23467666

Genetic Variants in MMP9 and TCF2 Contribute to Susceptibility to Lung Cancer.

Jing-Zhe Sun1, Xue-Xi Yang, Ni-Ya Hu, Xin Li, Fen-Xia Li, Ming Li.   

Abstract

OBJECTIVE: The Wnt signaling pathway is crucial for pulmonary development and differentiation; dysregulation of the Wnt signaling pathway may impair lung function. Indeed, single nucleotide polymorphisms (SNPs) of Wnt pathway-related genes have been suggested as risk factors for certain types of cancers. In this study, we aimed to evaluate the influence of SNPs in Wnt-related genes (TCF2, MMP9) on susceptibility to lung cancer.
METHODS: Polymorphisms of TCF2 rs4430796, MMP9 rs2250889, and MMP9 rs17576 were studied in Han Chinese subjects, including 135 patients with lung cancer and 176 controls, using the Sequenom MassARRAY platform. The association of genotypes with susceptibility to lung cancer was analyzed using odds ratio (OR), with 95% confidence interval (95% CI) and χ(2).
RESULTS: The three SNPs (rs4430796, rs2250889, and rs17576) were found to be significantly associated with an increased risk of lung cancer. The AA genotype and AG+AA genotype of rs4430796 showed a significantly increased susceptibility to lung cancer compared with the GG genotype (adjusted OR=6.03, 95% CI: 1.30-28.09, P=0.022; 5.55, 95% CI: 1.20-25.58, P=0.028). Compared with the rs17576 GG genotype, the AG and AG+AA genotypes were also associated with a significant risk (adjusted OR=2.65, 95% CI: 1.60-4.37, P≤0.001; 2.57, 95% CI: 1.59-4.19, P≤0.001) whereas the rs2250889 CG and CG+GG genotypes had 2.97-fold (95% CI: 1.81-4.85; P≤0.001) and 2.80-fold increased associations with lung cancer (95% CI: 1.73-4.54; P≤0.001), respectively, compared with the rs2250889 CC genotype. Furthermore, the association of rs4430796 with lung cancer became insignificant (P>0.05) after adjusting for gender and rs2250889.
CONCLUSION: The three SNPs may play a role in the predisposition of members of the Han Chinese population to lung cancer.

Entities:  

Keywords:  Lung cancer; MMP9; Single nucleotide polymorphisms (SNPs); Susceptibility; TCF2

Year:  2011        PMID: 23467666      PMCID: PMC3587563          DOI: 10.1007/s11670-011-0183-3

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  33 in total

1.  Association of moderate alpha-1 antitrypsin deficiency with lung cancer in the Serbian population.

Authors:  Aleksandra S Topic; Zorana D Jelic-Ivanovic; Vesna V Spasojevic-Kalimanovska; Slavica M Spasic
Journal:  Arch Med Res       Date:  2006-10       Impact factor: 2.235

Review 2.  Genotyping single nucleotide polymorphisms by MALDI mass spectrometry in clinical applications.

Authors:  Jörg Tost; Ivo Glynne Gut
Journal:  Clin Biochem       Date:  2005-04       Impact factor: 3.281

Review 3.  Developmental signalling pathways in lung cancer.

Authors:  Vincent C Daniel; Craig D Peacock; D Neil Watkins
Journal:  Respirology       Date:  2006-05       Impact factor: 6.424

4.  Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma.

Authors:  G Akiri; M M Cherian; S Vijayakumar; G Liu; A Bafico; S A Aaronson
Journal:  Oncogene       Date:  2009-04-20       Impact factor: 9.867

5.  Wnt antagonist gene polymorphisms and renal cancer.

Authors:  Hiroshi Hirata; Yuji Hinoda; Koichi Nakajima; Nobuyuki Kikuno; Soichiro Yamamura; Kazumori Kawakami; Yutaka Suehiro; Z Laura Tabatabai; Nobuhisa Ishii; Rajvir Dahiya
Journal:  Cancer       Date:  2009-10-01       Impact factor: 6.860

6.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

7.  Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer.

Authors:  Zhibin Hu; Xiang Huo; Daru Lu; Ji Qian; Jiannong Zhou; Yijiang Chen; Lin Xu; Hongxia Ma; Jingfu Zhu; Qingyi Wei; Hongbing Shen
Journal:  Clin Cancer Res       Date:  2005-08-01       Impact factor: 12.531

8.  WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis.

Authors:  Don X Nguyen; Anne C Chiang; Xiang H-F Zhang; Juliet Y Kim; Mark G Kris; Marc Ladanyi; William L Gerald; Joan Massagué
Journal:  Cell       Date:  2009-07-02       Impact factor: 41.582

9.  Prognostic Significance and Clinicopathological Associations of COX-2 SNP in Patients with Nonsmall Cell Lung Cancer.

Authors:  Peter P Grimminger; Jan Stöhlmacher; Daniel Vallböhmer; Paul M Schneider; Arnulf H Hölscher; Ralf Metzger; Peter V Danenberg; Jan Brabender
Journal:  J Oncol       Date:  2009-11-22       Impact factor: 4.375

10.  Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.

Authors:  K Terasawa; M Toyota; S Sagae; K Ogi; H Suzuki; T Sonoda; K Akino; R Maruyama; N Nishikawa; K Imai; Y Shinomura; T Saito; T Tokino
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

View more
  5 in total

1.  Polymorphisms in matrix metalloproteinases 2, 3, and 8 increase recurrence and mortality risk by regulating enzyme activity in gastric adenocarcinoma.

Authors:  Youdong Lin; Jinsheng Liu; Long Jin; Yun Jiang
Journal:  Oncotarget       Date:  2017-11-20

2.  Cumulative evidence for relationships between multiple variants of HNF1B and the risk of prostate and endometrial cancers.

Authors:  Yu Tong; Yi Qu; Shiping Li; Fengyan Zhao; Yibin Wang; Dezhi Mu
Journal:  BMC Med Genet       Date:  2018-07-27       Impact factor: 2.103

3.  Association of matrix metalloproteinase 2 and matrix metalloproteinase 9 gene polymorphism in aggressive and nonaggressive odontogenic lesions: A pilot study.

Authors:  Devu Aloka; S K Padmakumar; Sanish Sathyan; Maria Sebastian; Moinak Banerjee; V T Beena
Journal:  J Oral Maxillofac Pathol       Date:  2019 Jan-Apr

4.  Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma.

Authors:  Danijela Štrbac; Katja Goričar; Vita Dolžan; Viljem Kovač
Journal:  Dis Markers       Date:  2017-09-12       Impact factor: 3.434

5.  Lung cancer A549 cells suppressed with overexpressed HNF1B or PCDHA13 inhibited PI3K/AKT phosphorylation.

Authors:  Chunyan Kang; Lingxiao Wang; Dandan Wang; Xiuzhi Zhang; Jie Chen
Journal:  Transl Cancer Res       Date:  2020-06       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.